9-((2R,4S,5R)-4-Trimethylsilanyloxy-5-trimethylsilanyloxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ylamine | 64911-19-9
分子结构分类
中文名称
——
中文别名
——
英文名称
9-((2R,4S,5R)-4-Trimethylsilanyloxy-5-trimethylsilanyloxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ylamine
英文别名
9-[(2R,4S,5R)-4-trimethylsilyloxy-5-(trimethylsilyloxymethyl)oxolan-2-yl]purin-6-amine
CAS
64911-19-9
化学式
C16H29N5O3Si2
mdl
——
分子量
395.609
InChiKey
JJEWTFIJBUOVPH-YNEHKIRRSA-N
BEILSTEIN
——
EINECS
——
-
物化性质
-
计算性质
-
ADMET
-
安全信息
-
SDS
-
制备方法与用途
-
上下游信息
-
文献信息
-
表征谱图
-
同类化合物
-
相关功能分类
-
相关结构分类
物化性质
-
沸点：478.0±55.0 °C(Predicted)
-
密度：1.24±0.1 g/cm3(Predicted)
计算性质
-
辛醇/水分配系数(LogP)：2.77
-
重原子数：26
-
可旋转键数：6
-
环数：3.0
-
sp3杂化的碳原子比例：0.69
-
拓扑面积：97.3
-
氢给体数：1
-
氢受体数：7
上下游信息
-
上游原料
中文名称 英文名称 CAS号 化学式 分子量 2'-脱氧腺苷 2'-Deoxyadenosine 958-09-8 C10H13N5O3 251.245 -
下游产品
中文名称 英文名称 CAS号 化学式 分子量 2'-脱氧腺苷 2'-Deoxyadenosine 958-09-8 C10H13N5O3 251.245 —— 3',5'-bis-O-trimethylsilyl-N6-p-nitrophenylethoxycarbonyl-2'-deoxyadenosine 88091-73-0 C25H36N6O7Si2 588.768 —— N2-isobutyryl-2'-deoxyguanosine 190834-08-3 C14H19N5O4 321.336 —— Adenosine, 2'-deoxy-N-(1-oxo-4-pentenyl)- 173346-57-1 C15H19N5O4 333.347 —— N6-[(allyloxy)carbonyl]-2'-deoxyadenosine 158391-93-6 C14H17N5O5 335.319 N-(苯氧基乙酰基)-2'-脱氧腺苷 N6-(phenoxyacetyl)-2'-deoxyadenosine 110522-74-2 C18H19N5O5 385.379 N-苯甲酰基-2’-脱氧腺苷 N6-benzoyl-2'-deoxyadenosine 4546-72-9 C17H17N5O4 355.353 —— 6-N-Phenylacetyl-2'-deoxyadenosine 155138-06-0 C18H19N5O4 369.38 —— (1,1,1-trichloro-2-methylpropan-2-yl) N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]carbamate 87515-11-5 C15H18Cl3N5O5 454.697 —— 4-fluoro-N-(9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide 90335-44-7 C17H16FN5O4 373.344 —— 4-chloro-N-(9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide 90335-43-6 C17H16ClN5O4 389.798 5-O-(4,4-二甲氧基三苯甲游基)-2-脱氧腺苷酸 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxyadenosine 17331-22-5 C31H31N5O5 553.618 —— (2R,3S,5R)-2-(hydroxymethyl)-5-[6-[(2-nitrophenyl)sulfanylamino]purin-9-yl]oxolan-3-ol 89845-38-5 C16H16N6O5S 404.406 —— 2'-deoxy-N6-{[2-(4-nitrophenyl)ethoxy]carbonyl}adenosine 88091-69-4 C19H20N6O7 444.404 —— 2-Azidomethyl-N-[9-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-benzamide 289712-61-4 C18H18N8O4 410.392 —— N(6)-Monobutyryl-2'-deoxycyclic adenosine monophosphate 61866-09-9 C14H18N5O6P 383.301 —— 3'-O-Acetyl-6-N-phenylacetyl-2'-deoxyadenosine 155501-21-6 C20H21N5O5 411.417 —— [(2R,3S,5R)-3-hydroxy-5-[6-[(2-phenylacetyl)amino]purin-9-yl]oxolan-2-yl]methoxy-methylphosphinic acid 182688-61-5 C19H22N5O6P 447.387 —— N6,N6-dibenzoyldeoxyadenosine 6711-37-1 C24H21N5O5 459.461 —— 5'-O-DMT-N6-ibu-dA 190834-10-7 C35H37N5O6 623.709 —— benzhydryl (((2R,3S,5R)-3-hydroxy-5-(6-((tris(4-methoxyphenyl)methyl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl) bis(trimethylsilyl) silicate 1310452-00-6 C51H61N5O9Si3 972.33 —— 2-cyanoethyl 5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine 3'-(N,N-diisopropyl)phosphoramidite 140613-55-4 C40H48N7O6P 753.838 —— 2'-deoxy-N6-phthaloyladenosine 84765-88-8 C18H15N5O5 381.348 —— 6-N-(2,2'-bis(2-nitrophenyl)ethyloxycarbonyl)-2'-deoxyadenosine 243657-10-5 C25H23N7O9 565.499 —— 5'-O-Dimethoxytrityl-6-N-phenylacetyl-2'-deoxyadenosine 164013-23-4 C39H37N5O6 671.753 —— 5'-O-(dimethoxytrityl)-6-N-(2-nitrophenylsulfenyl)-deoxyadenosine 121637-76-1 C37H34N6O7S 706.779 —— 2'-deoxy-5'-O-(4-monomethoxytrityl)-N6-[2-(4-nitrophenyl)ethoxycarbonyl]adenosine 91608-32-1 C39H36N6O8 716.75 —— 2-Azidomethyl-N-(9-{(2R,4S,5R)-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-9H-purin-6-yl)-benzamide 329781-61-5 C39H36N8O6 712.765 —— 3'-O-Acetyl-5'-O-dimethoxytrityl-6-N-phenylacetyl-2'-deoxyadenosine 203986-32-7 C41H39N5O7 713.79 —— 2-[[tert-butyl(diphenyl)silyl]oxymethyl]-N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide 139036-61-6 C34H37N5O5Si 623.784